Xeprilia Trademark Details

Xeprilia was registered on Tuesday, August 12, 2003 and is currently owned by Sanofi-Aventis under the registration number 2749152 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 14 years ago on Sunday, March 14, 2010, according to the United State Patent & Trademark Office
Word Mark Xeprilia
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Sanofi-Aventis of Allen, TX

View all trademarks for Sanofi-Aventis
Other Trademarks for Sanofi-Aventis
Serial Number 75899417
Registration Number 2749152
Status Date Sunday, March 14, 2010
Filing Date Sunday, March 14, 2010
Registration Date Tuesday, August 12, 2003
Attorney William S. Frommer
Domestic Representative William S. Frommer

Correspondent

Susan Upton Douglass
Fross Zelnick Lehrman & Zissu, P.C.
866 United Nations Plaza
New York NY 10017

Case File Statements

Goods & Services Pharmaceutical Preparation for the Prevention and Treatment of Central and Nervous System Disorders, Particularly Amyotrophic Lateral Sclerosis

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 2 — Sec. 8 – Entire Registration
Status Date Sunday, March 14, 2010
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.